According to Mirum Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 4.63.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 5.53 | 9.32% |
2022-12-31 | 5.06 | 24.52% |
2021-12-31 | 4.07 | 34.56% |
2020-12-31 | 3.02 | -28.94% |
2019-12-31 | 4.25 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | -47.59% | ๐บ๐ธ USA |